Monday's Biggest Stock Gainers
Celanese Corp. (NYSE:CE - News) said it plans to buy back up to $400 million worth of its common stock in a modified Dutch auction tender offer. The chemical company, which is based in Dallas, also disclosed plans to a refinancing of its existing senior credit facilities, senior subordinated notes and senior discount notes. The company expects the plan to reduce debt by more than $200 million.
Myriad Genetics (NasdaqGS:MYGN - News) said a follow-on Phase 2 study of Flurizan shows that it may be capable, not only of slowing the decline of Alzheimer's disease, but of halting the disease in its tracks. "This analysis of patient response to Flurizan in the Phase 2 trial suggests that the drug may, in many patients, actually halt disease progression over a 24-month time frame. Since Flurizan appears to slow the biological progression of the disease, this is an exciting and novel finding, and if replicated in the ongoing Phase 3 trials will be extraordinarily important," the company said.
Shares of Pathmark Stores (NasdaqGM:PTMK - News) rallied after the company agreed to be acquired by Great Atlantic & Pacific Tea Co. (NYSE:GAP - News) for $1.3 billion in cash, stock and assumed debt.
Published By MarketWatch
Myriad Genetics (NasdaqGS:MYGN - News) said a follow-on Phase 2 study of Flurizan shows that it may be capable, not only of slowing the decline of Alzheimer's disease, but of halting the disease in its tracks. "This analysis of patient response to Flurizan in the Phase 2 trial suggests that the drug may, in many patients, actually halt disease progression over a 24-month time frame. Since Flurizan appears to slow the biological progression of the disease, this is an exciting and novel finding, and if replicated in the ongoing Phase 3 trials will be extraordinarily important," the company said.
Shares of Pathmark Stores (NasdaqGM:PTMK - News) rallied after the company agreed to be acquired by Great Atlantic & Pacific Tea Co. (NYSE:GAP - News) for $1.3 billion in cash, stock and assumed debt.
Published By MarketWatch






0 Comments:
Post a Comment
<< Home